Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders
制定针对焦虑症的低强度初级保健干预措施
基本信息
- 批准号:8986209
- 负责人:
- 金额:$ 24.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-09 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAffectAgoraphobiaAmericanAnxietyAnxiety DisordersAttentionBenchmarkingCaringClinicCognitiveCognitive TherapyComorbidityComplexComputersDataDevelopmentDiagnosisDiagnostic SpecificityDisease remissionDouble-Blind MethodEarly treatmentEffectivenessEvaluationFeedbackFutureGeneralized Anxiety DisorderGoalsHealthHealth Care CostsHome environmentHybridsImpairmentImprove AccessIndividualInterventionLeadLinkMental HealthMental disordersMethodsModificationMonitorNursesOccupationalPanic DisorderParticipantPatient PreferencesPatient-Focused OutcomesPatientsPharmacotherapyPopulationPrimary Health CareProceduresProtocols documentationProviderPsychotherapyPublic HealthRandomized Controlled TrialsResearchResourcesSelf-AdministeredSeveritiesSocial PhobiaStimulusSystemTestingTimeTrainingTraining ProgramsTreatment StepWorkanxiety symptomsanxiety treatmentanxiousbasecare deliverycognitive trainingcomputerizeddesigndisabilityeffective therapyexperiencemeetingsprimary care settingprimary outcomeprogramspsychosocialsecondary outcomesocialtherapy developmenttreatment response
项目摘要
DESCRIPTION (provided by applicant): Anxiety disorders are the most common class of mental health problem in the U.S. population and are highly prevalent in primary care. Although they are associated with great social, educational, and occupational impairment, and with increased health care costs, few people receive adequate treatment. There is a great need for low-intensity, scalable, non-pharmacological interventions. While not all patients may achieve remission after these first-step treatments, they are necessary to achieve the greatest reduction in suffering across the population at large. Cognitive Bias Modification (CBM), which uses simple computer tasks to directly target cognitive vulnerability to anxiety disorders, is an ideal candidate for a first-step, scalable intervention. CBM is computerized and requires minimal training or provider time. Ideally, CBM delivery would be linked to primary care, as this is the setting where the majority of anxious patients first present for care. Further, primary care-linked
delivery will allow for primary care provider (PCP) monitoring of patient outcomes and provision of more intensive treatments as needed. The overarching goal of this study is thus to develop and refine CBM so that it is feasible and acceptable to deliver in the primary care setting. First,
we will tailor CBM for primary care by developing the first transdiagnostic and personalized CBM. Entitled "Attention and Interpretation Modification (AIM)", this CBM will comprise both a computerized assessment to develop a personalized set of stimuli and a treatment, which corrects attention and interpretation biases. AIM will be delivered via 8, 30-minute computer sessions. To further facilitate future implementation, we will develop methods for primary care linked delivery of AIM, including an option to complete sessions at home while still being monitored by the PCP. Our development work will be informed by ongoing evaluation with an Advisory Panel (AP) of PCPs, practice leaders, nurses, and patients, and by our team's experience creating quick, easily interpretable PCP feedback systems via use of paraprofessional Patient Navigators. We will conduct an open trial of AIM (n = 18) to attain feasibility and acceptability data and experience to help us refine AIM and delivery methods. Next, we will conduct a pilot, double-blind randomized controlled trial (RCT; n=42). The pilot RCT will allow us to examine the feasibility and acceptability of AIM and of our research procedures for an eventual full-scale RCT. Further, both trials will allow us to pilot potential moderators including baseline attentional and interpretational bias and specific anxiety disorder diagnosis. In the future large-scale RCT, anxiety symptom severity will be the primary outcome and psychosocial functioning will be the secondary outcome. Achievement of these aims will prepare us to apply for a future R01 to conduct a large-scale, adequately powered, hybrid effectiveness-implementation RCT testing AIM, a primary care-linked, personalized CBM. This line of work will lead to the incorporation into primary care of readily scalable, translational, effective, non-pharmacological mental health treatment for patients with anxiety disorders.
描述(由申请人提供):焦虑症是美国人口中最常见的一类心理健康问题,在初级保健中非常普遍。尽管它们与严重的社会、教育和职业障碍以及医疗保健成本增加有关,但很少有人得到充分的治疗。非常需要低强度、可扩展的非药物干预措施。虽然并非所有患者都可以在这些第一步治疗后获得缓解,但它们是实现最大程度减少整个人群痛苦的必要条件。认知偏差修正(CBM)使用简单的计算机任务直接针对焦虑症的认知脆弱性,是第一步可扩展干预的理想候选方案。建立信任措施是计算机化的,需要最少的培训或提供者的时间。理想情况下,煤层气的提供将与初级保健联系起来,因为这是大多数焦虑患者首次接受护理的环境。此外,与初级保健有关的
交付将允许初级保健提供者(PCP)监测患者的结果,并根据需要提供更密集的治疗。因此,本研究的总体目标是制定和完善CBM,以便在初级保健环境中提供可行和可接受的服务。第一、
我们将通过开发第一个跨诊断和个性化的CBM,为初级保健定制CBM。这一被称为“注意力和解释修正(AIM)"的CBM将包括一个计算机化的评估,以开发一套个性化的刺激和治疗,纠正注意力和解释偏差。AIM将通过8个30分钟的计算机会话进行。为了进一步促进未来的实施,我们将制定与初级保健相关的AIM提供方法,包括在家中完成会话的选项,同时仍由PCP进行监测。我们的开发工作将通过咨询小组(AP)对PCP,实践领导者,护士和患者的持续评估,以及我们团队通过使用准专业患者导航器创建快速,易于解释的PCP反馈系统的经验来了解。我们将进行一项AIM的开放试验(n = 18),以获得可行性和可接受性数据和经验,帮助我们完善AIM和交付方法。接下来,我们将进行一项先导性双盲随机对照试验(RCT; n=42)。试点随机对照试验将使我们能够检查AIM的可行性和可接受性,以及我们最终全面随机对照试验的研究程序。此外,这两项试验将使我们能够试验潜在的调节因素,包括基线注意力和解释偏差以及特定的焦虑症诊断。在未来的大规模随机对照试验中,焦虑症状严重程度将是主要结局,心理社会功能将是次要结局。这些目标的实现将使我们准备申请未来的R 01,以进行大规模的,充分的动力,混合有效性实施RCT测试AIM,一个初级保健相关的,个性化的CBM。这项工作将导致纳入初级保健的容易扩展,翻译,有效,非药物的精神健康治疗焦虑症患者。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Development of a cognitive bias modification intervention for anxiety disorders in primary care.
初级保健中针对焦虑症的认知偏差修正干预措施的开发。
- DOI:10.1111/bjc.12281
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Weisberg,RisaB;Gonsalves,MeghanA;Ramadurai,Ramya;Braham,Howard;Fuchs,Cara;Beard,Courtney
- 通讯作者:Beard,Courtney
A systematic review of the word sentence association paradigm (WSAP).
- DOI:10.1016/j.jbtep.2019.04.003
- 发表时间:2019-09
- 期刊:
- 影响因子:1.8
- 作者:Gonsalves, Meghan;Whittles, Randy L.;Weisberg, Risa B.;Beard, Courtney
- 通讯作者:Beard, Courtney
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Courtney Beard Elias其他文献
Courtney Beard Elias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Courtney Beard Elias', 18)}}的其他基金
Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety
父母解释偏差是焦虑代际传递的关键机制
- 批准号:
10583856 - 财政年份:2023
- 资助金额:
$ 24.11万 - 项目类别:
Augmenting hospitalization for SMI by targeting interpretation bias
通过消除解释偏差来增加 SMI 的住院率
- 批准号:
9933163 - 财政年份:2019
- 资助金额:
$ 24.11万 - 项目类别:
Augmenting hospitalization for SMI by targeting interpretation bias
通过消除解释偏差来增加 SMI 的住院率
- 批准号:
9893902 - 财政年份:2018
- 资助金额:
$ 24.11万 - 项目类别:
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders
制定针对焦虑症的低强度初级保健干预措施
- 批准号:
8636616 - 财政年份:2014
- 资助金额:
$ 24.11万 - 项目类别:
Information Processing Training for Social Phobia in Primary Care
初级保健中社交恐惧症的信息处理培训
- 批准号:
7612347 - 财政年份:2008
- 资助金额:
$ 24.11万 - 项目类别:
Information Processing Training for Social Phobia in Primary Care
初级保健中社交恐惧症的信息处理培训
- 批准号:
7743802 - 财政年份:2008
- 资助金额:
$ 24.11万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.11万 - 项目类别:
Research Grant